Start here if you're new
what it is
CME runs the marketplace where institutions bet on interest rates, stocks, currencies, oil, and crops.
how it gets paid
Last year CME made $6.5B in revenue. Clearing & transaction fees was the main engine at $5.27B, or 81% of sales.
why it's growing
Revenue grew 6.4% last year. Indeed, cme has benefited from stronger trading volume, as well as greater demand for risk-management products and other offerings.
what just happened
Latest earnings delivered $2.77 in EPS versus a $2.58 estimate, a 7.36% beat.
At a glance
A+ balance sheet — rock-solid finances — built to survive anything
75/100 earnings predictability — reasonably predictable
26.0x trailing p/e — priced about right
1.9% dividend yield — cash in your pocket every quarter
10.5% return on capital — nothing to write home about
xvary composite: 80/100 — above average
What they do
CME runs the marketplace where institutions bet on interest rates, stocks, currencies, oil, and crops.
Derivatives → contracts on rates, stocks, oil, and crops → so what: when markets get jumpy, people need this venue. Clearing and transaction fees were 81% of 2024 revenue, and operating margin was 64.9%. Liquidity (lots of buyers and sellers) → better pricing for your trade → so what: you go where everyone else already is, and that habit is hard to break.
How they make money
$6.5B
annual revenue · their business grew +6.4% last year
Clearing & transaction fees
$5.27B
Market data
$0.39B
Information services
$0.39B
Other
$0.46B
The products that matter
derivatives trading and clearing
Exchange and Clearing Platform
$6.5B revenue · ~58.3% net margin
It is the business: $6.5B in annual revenue from matching, clearing, and settling risk transfers. The margin tells you this is not commodity finance.
market plumbing
Key numbers
64.9%
operating margin
Operating margin → how much profit remains after running the business → so what: CME keeps almost $0.65 of every revenue dollar before interest and taxes.
$3.4B
long-term debt
Debt-to-capital → how much of the business is financed with borrowing → so what: at just 3% of capital, balance-sheet stress is not your main problem here.
58.3%
net margin
Net profit margin → what is left after nearly everything → so what: more than half of revenue ends up as profit, which is absurd in plain English.
10.5%
return on capital
Return on capital → profit earned on the money tied up in the business → so what: decent, but not magic, which matters when the stock trades at 26.0x earnings.
Financial health
A+
strength
- balance sheet grade A+ — near the highest rating possible
- risk rank 1 — safer than 95% of stocks
- price stability 100 / 100
- long-term debt $3.4B (3% of capital)
- net profit margin 58.3% — keeps 58 cents of every dollar in revenue
- return on equity 12% — $0.12 profit for every $1 investors have put in
A+ with balance sheet grade and risk rank standing out. your money faces less risk here than at most public companies.
Total return vs. market
You invested $10,000 in CME 3 years ago → it's now worth $18,120.
The index would have given you $13,920.
source: institutional data · total return
What just happened
beat estimates
Latest earnings delivered $2.77 in EPS versus a $2.58 estimate, a 7.36% beat.
Revenue was $1.6B, up 8% vs. prior year, and annual revenue was $6.5B, up 6.4%. Quarterly EPS history shows $2.58 for 2025's fourth quarter, while consensus lists the latest print at $2.77, so you should treat that gap as a reporting-basis difference.
$1.6B
revenue (Q)
$2.77
eps (Q)
7.36%
surprise
the number that mattered
The 7.36% EPS beat matters most because CME already trades at 26.0x earnings, so it needs to keep clearing a high bar.
-
cme group likely recorded stellar gains in 2025.
-
rising geopolitical tensions, tariff and global trade concerns, as well as worries about the u.s. economy have led to market turbulence over the past few quarters, which has enabled the exchange operator to break several records, thanks to robust trading activity across its various asset classes.cme’s top and bottom lines receded slightly during the september quarter, owing to lackluster comparisons to the dynamic showing in the year-ago period, and were probably limp in the december stanza.
-
nevertheless, we believe earnings per share increased 9%, on a 6% revenue advance, for the full year.
-
the exchange operator ought to build steam in the near term.
-
dynamic market activity may well persist in the coming months.indeed, cme has benefited from stronger trading volume, as well as greater demand for risk-management products and other offerings. we think management’s ongoing cost controls and business improvements will spur results moving forward. all told, the top and bottom lines will probably advance at a low- to mid-single-digit clip through 2026.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the #1 risk is lower derivatives volume after volatility cools.
med
volatility fades and contracts fall
CME gets paid when clients hedge, speculate, and rebalance risk. Quieter markets usually mean fewer contracts moving through the exchange.
Q4 estimates already call for $1.5B in revenue, down 3% from a year ago. If that turns into a multi-quarter pattern, the premium valuation stops feeling defensive and starts feeling full.
med
regulatory pressure on clearing and market structure
This is a heavily regulated business. Changes to futures rules, clearing requirements, or fee practices can hit economics even when demand stays healthy.
With a 57.9% net margin, CME has a lot to protect. Even modest pressure on pricing or compliance costs would show up quickly in profitability.
med
the stock already prices in quality
A+ finances, 100 / 100 price stability, and a 26.0x trailing p/e do not leave much room for operational sloppiness.
This is the classic great-business problem. If growth slows while the multiple stays rich, you can own a very good company and still get a mediocre return.
CME is more stable than the markets it serves, but not immune to them. When volumes soften, the business still works — the stock just stops looking cheap.
source: institutional data · regulatory filings · risk analysis
Pay attention to
metric
annual growth vs. quarterly slowdown
Revenue grew 6.4% last year, but the next quarter is set up for a 3% decline from a year ago. That gap is the thing to watch.
trend
whether market volatility stays elevated
More volatility usually means more hedging, and more hedging usually means better exchange volume.
risk
regulatory changes around clearing
This is one of those businesses where rule changes matter almost as much as market conditions.
calendar
the next earnings print
If CME can post $2.70 EPS on $1.5B revenue and talk confidently about volume, the durability case stays intact.
Analyst rankings
short-term outlook
average
Momentum score 3. In human-speak, analysts do not see a strong short-term signal either way.
risk profile
safest 5%
Stability score 1 — lower risk of permanent capital damage than almost any stock.
chart momentum
top 20%
Technical score 2 — in human-speak, the chart still looks better than most.
earnings predictability
75 / 100
Results are usually reliable, but quarterly trading activity can still make comparisons lumpy.
source: institutional data
Institutional activity
institutions have been net buying for 3 consecutive quarters — 757 buyers vs. 719 sellers in 3q2025. total institutional holdings: 0.3B shares. net buying for 3 quarters.
source: institutional data
Price targets
3-5 year target range
$238
$347
$273
current price
$293
target midpoint · +7% from current · 3-5yr high: $310 (+15% · 5% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive